Excelsior Sciences
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $70M
Investors
- 7
About Excelsior Sciences
Excelsior Sciences focuses on innovative solutions in small-molecule chemistry. The company was founded in New York, US, and has not undergone significant pivots in its business strategy.Excelsior Sciences develops innovative small-molecule solutions through its proprietary smart blocc platform, which revolutionizes the traditional chemistry synthesis process by making it accessible to automation, artificial intelligence, and non-specialists. The company's primary offerings focus on modular, machine-ready chemical building blocks, enabling rapid carbon-carbon bond formation. These products address critical challenges in the pharmaceutical, materials science, and agricultural technology sectors, facilitating the discovery and manufacturing of new medicines and materials at unprecedented speeds.00 mn grant from New York’s Empire State Development. Revenue primarily stems from partnerships with pharmaceutical and materials science companies, utilizing smart bloccs in small-molecule discovery and manufacturing, generating transactional revenue through B2B engagements. The company plans to expand its market presence by building partnerships across therapeutics and materials science while supporting reshoring initiatives.
Who invested in Excelsior Sciences
7 investors across 1 round
See all investors in Excelsior Sciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 3, 2025
Amount
$70M
Investors
Questions about Excelsior Sciences
Who invested in Excelsior Sciences?
Excelsior Sciences has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Excelsior Sciences raised?
Excelsior Sciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Excelsior Sciences last raise money?
Excelsior Sciences's most recent round on record is a Series A, in Dec 2025.
What does Excelsior Sciences do?
Excelsior Sciences focuses on innovative solutions in small-molecule chemistry.
Where is Excelsior Sciences headquartered?
Excelsior Sciences is headquartered in New York, US.
Which VCs invest in companies like Excelsior Sciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Excelsior Sciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Excelsior Sciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.